Choose a channel
Check out the different Progress in Mind content channels.
Welcome to Progress in Mind’s live coverage of EAN 2022. This 8th Congress of the European Academy of Neurology – Vienna 2022 – continued into its third day, June 27th. The Plenary Symposium covered topics including diagnostic technologies in neurology and how research and guidelines can inform clinical practice. Symposia included sessions discussing first line therapy in migraine; dementia diagnosis in Latin American countries; evaluation and treatment of neuromuscular disorders in Arab nations; and therapeutic strategies for Parkinson’s disease. The many teaching sessions and workshops including topics such as neuro-COVID; palliative care; biomarker-based diagnosis; and the use of big data in neuroepidemiology. Here is a summary of today’s (Day 3) highlights from this hybrid in-person and online conference in Vienna.
Important lessons from the plenary symposium
Today’s Plenary Symposium at EAN included Carl E. Clarke discussing whether neurology trials informed clinical practice; Cristina Granziera asking how appropriate development and implementation of diagnostic technologies in neurology can be ensured; Maurizio A. Leone questioning whether guidelines were a useful tool for improving neurology outcomes; and Barbara Tettenborn discussing how, in an era of information overload and increasing complexity, neurologists can find what is important and relevant to their practice.
Treatment strategies for best practices
There is debate on how newer therapies fit into current strategies in neurology
Controversy session, symposia, and special symposia including a variety of topics:
Oral sessions and ePresentations included continuation of a number of topics such as ageing, dementia, and sleep-wake disorders; autonomic nervous system diseases and peripheral nerve disorders; neurogenetics, neuroepidemiology and neurological manifestation of systemic diseases; neuroimmunology; motor neuron disease; neuro-oncology; MS and related disorders; cerebrovascular diseases; movement disorders; COVID-19 and infectious diseases; and epilepsy.
There were also sessions on neuro-ophthalmology/neuro-otology and coma and chronic disorders of consciousness; neurocritical care; autonomic nervous system diseases; and neurogenetics.
Sessions continue in the realms of multiple sclerosis, Parkinson’s disease, and post-COVID-19 infection issues
In the ‘scientific theatre,’ talks included:
Several satellite symposia took place, covering the topics of MS and related disorders; headache, migraine and pain; movement disorders; aging and dementia; rare muscle and neuromuscular junction diseases; neurological manifestations of systemic diseases, and peripheral nerve disorders; and education in neurology.
Opportunities to extend clinical practices
Today also included a number of focused and case based workshops; hands-on and teaching courses; and interactive sessions with choices including:
Practical sessions combined with neurologist-led teaching
Our correspondent’s highlights from the symposium are meant as a fair representation of the scientific content presented. The views and opinions expressed on this page do not necessarily reflect those of Lundbeck.